Jim Slattery

发表的论文20 篇，按出版时间

1. 1
   The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse ReactionsDrug Safety202117
2. 2
   Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident UsersDrug Safety202113
3. 3
   Does additional monitoring status increase the reporting of adverse drug reaction s ? An interrupted time series analysis of EudraVigilance dataPharmacoepidemiology and Drug Safety20208
4. 4
   What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?Pharmacoepidemiology and Drug Safety202018
5. 5
   Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?Pharmacoepidemiology and Drug Safety202014
6. 6
   Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeDrug Safety201834
7. 7
   EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health ProtectionDrug Safety2018136
8. 8
   Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?Pharmacoepidemiology and Drug Safety20176
9. 9
   An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilancePharmacoepidemiology and Drug Safety201716
10. 10
    Patient Reporting in the EU: Analysis of EudraVigilance DataDrug Safety201782